Ingenium Therapeutics

Developer of anti-cancer immunotherapy treatments

placeYuseong, Daejeon, South Korea calendar_todayFounded 2020 groups14 employees language ingeniumcell.co.kr

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace active. Cited 9 times.

YearFilings
20241
20251

Investor mix

3 investors on record; lead investors include Capstone Partners.

Investor typeCountShare
Venture capital3100%
Coming soon